| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 珀莱雅 603605 | 定价权·品牌 | 化妆品 | 13.4 | 13.8 | — | 3.75 | 3.1% | 43% | 70% | 10% | 0.5 | 6.7% | +18% | -18% | -6% | -27% | -40% | 32% | 250 |
| 贝泰妮 300957 | 轻资产现金牛 | 化妆品 | 25.8 | 22.1 | 1.30 | 2.31 | 1.9% | 50% | 74% | 8% | 0.8 | 6.5% | +2% | -6% | -14% | -28% | -40% | 34% | 142 |
| 丸美生物 603983 | 中性 | 化妆品 | 58.5 | 41.1 | 1.79 | 3.95 | 1.5% | 81% | 71% | 20% | 1.8 | -0.1% | +26% | +5% | +1% | -20% | -49% | 40% | 133 |
| 上海家化 600315 | 中性 | 化妆品 | 32.7 | 28.8 | 1.25 | 1.77 | 1.3% | 50% | 59% | 6% | 1.2 | 3.5% | -4% | +34% | -17% | -28% | -43% | 35% | 125 |
| 敷尔佳 301371 | 定价权·品牌 | 化妆品 | 24.6 | 22.5 | 1.50 | 2.04 | 3.7% | 91% | 82% | 10% | 0.0 | 3.1% | +2% | -16% | -5% | -17% | -35% | 38% | 113 |
| 水羊股份 300740 | 中性 | 化妆品 | 88.6 | 44.1 | 1.42 | 4.37 | 0.4% | 20% | 58% | 20% | 5.1 | 5.5% | +2% | +81% | -5% | +5% | -41% | 55% | 99 |
| 福瑞达 600223 | 中性 | 化妆品 | 35.7 | 26.1 | 1.19 | 1.36 | 1.0% | 33% | 46% | 20% | 0.3 | 3.5% | -34% | -2% | -22% | -32% | -42% | 24% | 58 |
| 科思股份 300856 | 中性 | 化妆品 | 50.5 | 29.6 | 1.23 | 1.92 | 0.7% | 35% | 37% | 51% | 1.9 | 1.3% | -6% | -26% | -20% | -31% | -38% | 37% | 51 |
| 维琪科技 920176 | 中性 | 化妆品 | 44.2 | — | — | 6.38 | — | — | 67% | 28% | 0.2 | -0.8% | +27% | — | — | — | — | — | 41 |
| 青岛金王 002094 | 亏损或困境 | 化妆品 | — | — | — | 2.70 | — | — | 13% | 12% | 12.2 | -4.0% | -17% | +39% | -25% | -36% | -54% | 36% | 40 |
| 锦盛新材 300849 | 重资产陷阱 | 化妆品 | — | — | — | 6.49 | — | — | 16% | 44% | 4.9 | -1.9% | +8% | +11% | +48% | +71% | -39% | 59% | 35 |
| 拉芳家化 603630 | 中性 | 化妆品 | — | — | — | 1.73 | — | 76% | 48% | 22% | 0.1 | -2.5% | -3% | +41% | -24% | -41% | -60% | 47% | 33 |
| 诺斯贝尔 300132 | 成长兑现 | 化妆品 | 18.0 | 18.2 | 0.76 | 2.18 | — | — | 13% | 13% | 0.6 | 8.4% | -9% | +77% | -27% | -1% | -44% | 41% | 33 |
| 嘉亨家化 300955 | 亏损或困境 | 化妆品 | — | 224.1 | 0.28 | 3.41 | — | 88% | 24% | 55% | 6.9 | 0.2% | +3% | +168% | -30% | +43% | -42% | 68% | 29 |
| 珈凯生物 920165 | 定价权·品牌 | 化妆品 | 24.2 | — | — | 3.76 | — | — | 63% | 0% | 0.1 | 4.4% | +13% | — | — | — | — | — | 18 |
| 芭薇股份 920123 | 中性 | 化妆品 | 30.3 | 28.8 | 1.44 | 3.16 | 1.7% | 57% | 29% | 42% | 2.2 | 2.8% | +22% | +40% | -20% | — | — | — | 13 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。